Eupraxia Pharmaceuticals Inc.
EPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001581178
No open-market purchases or sales by Eupraxia Pharmaceuticals Inc. insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $163.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Eupraxia Pharmaceuticals Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +9 vs. Q3 2025
- Shares held
- 13.9M
- +1.14M (+8.9%) vs. Q3 2025
- Total value
- $105.1M
- +$29.8M (+39.6%) vs. Q3 2025
- New holders
- 15
- 8 more added
- Sold out
- 6
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 67 | $163.6M |
| Q1 2026 | 55 | $160.3M |
| Q4 2025 | 36 | $105.1M |
| Q3 2025 | 27 | $75.3M |
| Q2 2025 | 14 | $10.9M |
| Q1 2025 | 11 | $7.09M |
| Q4 2024 | 9 | $5.63M |
| Q3 2024 | 8 | $4.55M |
| Q2 2024 | 8 | $4.43M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Eupraxia Pharmaceuticals Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 3,709,373 | $27.9M | 0.17% | −349,526−8.6% | Reduced |
| Balyasny Asset Management LLC | 1,350,000 | $10.2M | 0.02% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,350,000 | $10.2M | 0.66% | 00.0% | Unchanged |
| Scotia Capital Inc. | 1,286,183 | $9.60M | 0.04% | +8,298+0.6% | Added |
| Great Point Partners LLC | 1,200,000 | $9.06M | 2.94% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 712,104 | $5.38M | 0.01% | +712,104 | New |
| Ikarian Capital, LLC | 610,000 | $4.61M | 0.60% | +610,000 | New |
| Squadron Capital Management LLC | 500,000 | $3.77M | 1.68% | +500,000 | New |
| Ally Bridge Group (NY) LLC | 397,895 | $3.00M | 4.77% | −517,105−56.5% | Reduced |
| Velan Capital Investment Management LP | 352,000 | $2.66M | 1.55% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 300,000 | $2.27M | 0.16% | 00.0% | Unchanged |
| Arrowstreet Capital, Limited Partnership | 278,064 | $2.09M | 0.00% | +278,064 | New |
| Bank of America Corp | 253,321 | $1.91M | 0.00% | +207,744+455.8% | Added |
| UBS Group AG | 220,024 | $1.66M | 0.00% | +124,268+129.8% | Added |
| Royal Bank of Canada | 196,277 | $1.48M | 0.00% | −232,527−54.2% | Reduced |
| SummitTX Capital, L.P. | 175,948 | $1.33M | 0.04% | +175,948 | New |
| Marshall Wace, LLP | 158,133 | $1.19M | 0.00% | +158,133 | New |
| Boothbay Fund Management, LLC | 156,331 | $1.18M | 0.03% | +156,331 | New |
| Acadian Asset Management LLC | 155,766 | $1.17M | 0.00% | +134,366+627.9% | Added |
| Delaney Capital Management Ltd. | 119,400 | $899.0K | 0.15% | +119,400 | New |
| Ingalls & Snyder LLC | 77,400 | $584.0K | 0.02% | +18,300+31.0% | Added |
| Goldman Sachs Group Inc | 58,058 | $438.3K | 0.00% | +17,958+44.8% | Added |
| CIBC World Markets Inc. | 58,050 | $436.5K | 0.00% | +43,050+287.0% | Added |
| Raymond James Financial Inc | 52,972 | $399.9K | 0.00% | +19,599+58.7% | Added |
| Quadrature Capital Ltd | 43,186 | $325.6K | 0.00% | +43,186 | New |
| Bank of Montreal | 37,250 | $280.1K | 0.00% | 00.0% | Unchanged |
| 1832 Asset Management L.P. | 32,138 | $242.6K | 0.00% | +32,138 | New |
| Jane Street Group, LLC | 29,622 | $222.8K | 0.00% | +29,622 | New |
| XTX Topco Ltd | 16,180 | $122.2K | 0.00% | +16,180 | New |
| Geode Capital Management, LLC | 13,899 | $104.9K | 0.00% | +13,899 | New |
| TCI Wealth Advisors, Inc. | 11,000 | $83.0K | 0.00% | 00.0% | Unchanged |
| Aptus Capital Advisors, LLC | 10,000 | $75.5K | 0.00% | +10,000 | New |
| Guardian Wealth Advisors, LLC | 10,000 | $75.5K | 0.00% | +10,000 | New |
| TD Waterhouse Canada Inc. | 9,600 | $71.7K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 9,091 | $67.9K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 586 | $4.44K | 0.00% | −296−33.6% | Reduced |
| Logos Global Management LP | 0 | $0 | 0.00% | −900,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Guardian Partners Inc. | 0 | $0 | 0.00% | −24,130−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −16,467−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −9−100.0% | Sold out |